ArticleOncoTargets and therapy2017

The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy.

Yuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.